In addition, they will also examine the effects of specific enhancement and depletion of GSH on longevity, using lifelong feeding with GSH monoethyl ester and buthionine sulfoximine, respectively
Provide a complete medication history, including all prescription drugs, over-the-counter medicines, herbal supplements, and vitamins you are currently taking
Recent topline results from the SURMOUNT-5 trial show the impact of Zepbound (tirzepatide): 20.2% average weight reduction with tirzepatide compared to -13.7% with semaglutide 47% greater relative reduction in weight Over 31% of patients on tirzepatide achieved 25% weight loss While full peer-reviewed results are pending, these findings reinforce growing evidence that dual GIP/GLP-1 receptor agonists like tirzepatide may offer significant metabolic benefits
International Journal of Molecular Sciences, 25 (8), 4346
(2023) 46(1):S14057
Udell JA, Bhatt DL, Braunwald E, Cavender MA, Mosenzon O, Steg PG, Davidson JA, Nicolau JC, Corbalan R, Hirshberg B, Frederich R, Im K, Umez-Eronini AA, He P, McGuire DK, Leiter LA, Raz I, Scirica BM, SAVOR-TIMI 53 Steering Committee and Investigators